Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Haase

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
Leukemia|July 5, 2016
Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study groupF Theis, A Corbacioglu, V I Gaidzik, et al.
Leukemia|May 3, 2016
Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)M Mossner, J-C Jann, D Nowak, et al.
Leukemia|February 1, 2012
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter studyU Germing, M Lauseker, B Hildebrandt, et al.
Leukemia|February 8, 2019
Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidineR F Schlenk, D Weber, W Herr, et al.
Leukemia|October 1, 2010
Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5qM Mallo, J Cervera, J Schanz, et al.
Leukemia|February 28, 2015
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)M G Della Porta, H Tuechler, L Malcovati, et al.
Leukemia|February 7, 2012
Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working GroupT M Westers, R Ireland, W Kern, et al.
Nature Cancer|May 26, 2025
Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor-ligand interactionsAlexander Beck, Lisa Gabler-Pamer, Gustavo Alencastro Veiga Cruzeiro, et al.
Nature|May 6, 2026
Author Correction: Multidimensional profiling of heterogeneity in supratentorial ependymomasDaeun Jeong, Sara G Danielli, Kendra K Maaß, et al.
Nature|March 12, 2026
Multidimensional profiling of heterogeneity in supratentorial ependymomasDaeun Jeong, Sara G Danielli, Kendra K Maaß, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Leukemia|July 5, 2016
Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study groupF Theis, A Corbacioglu, V I Gaidzik, et al.
Leukemia|May 3, 2016
Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)M Mossner, J-C Jann, D Nowak, et al.
Leukemia|February 1, 2012
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter studyU Germing, M Lauseker, B Hildebrandt, et al.
Leukemia|February 8, 2019
Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidineR F Schlenk, D Weber, W Herr, et al.
Leukemia|October 1, 2010
Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5qM Mallo, J Cervera, J Schanz, et al.
Leukemia|February 28, 2015
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)M G Della Porta, H Tuechler, L Malcovati, et al.
Leukemia|February 7, 2012
Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working GroupT M Westers, R Ireland, W Kern, et al.
Nature Cancer|May 26, 2025
Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor-ligand interactionsAlexander Beck, Lisa Gabler-Pamer, Gustavo Alencastro Veiga Cruzeiro, et al.
Nature|May 6, 2026
Author Correction: Multidimensional profiling of heterogeneity in supratentorial ependymomasDaeun Jeong, Sara G Danielli, Kendra K Maaß, et al.
Nature|March 12, 2026
Multidimensional profiling of heterogeneity in supratentorial ependymomasDaeun Jeong, Sara G Danielli, Kendra K Maaß, et al.
Pageof 15